Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Trial of NovoTTF-200A Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM

NCT03780569 is registered in ClinicalTrials.gov with NovoCure Ltd. as lead sponsor.

NCT NCT03780569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03780569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Trial of NovoTTF-200A Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
Lead sponsor
NovoCure Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
April 27, 2017
Completion date
January 31, 2019
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme